Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Nygaard, Tyler K ^a   Pallister, Kyler B ^a   DuMont, Ashley L ^b   DeWald, Mark ^a   Watkins, Robert L ^a   Pallister, Erik Q ^a   Malone, Cheryl ^c   Griffith, Shannon ^a   Horswill, Alexander R ^c   Torres, Victor J ^b   Voyich, Jovanka M ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; HLA ANTIGEN; LIPOCORTIN 5; BACTERIAL TOXIN; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENSITOMETRY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PLASMID; POLYMORPHONUCLEAR CELL; T LYMPHOCYTE; CELL LINE; CELL MEMBRANE PERMEABILITY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; GENE DELETION; GENETICS; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MONONUCLEAR CELL; NEUTROPHIL; PHYSIOLOGY;

STAPHYLOCOCCUS AUREUS;

APOPTOSIS; B-LYMPHOCYTES; BACTERIAL TOXINS; CELL LINE; CELL MEMBRANE PERMEABILITY; CULTURE MEDIA, CONDITIONED; HUMANS; LEUKOCYTES, MONONUCLEAR; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MONOCYTES; NEUTROPHILS; RECOMBINANT PROTEINS; SEQUENCE DELETION; T-LYMPHOCYTES;

EID: 84860528434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036532     Document Type: Article

References (46)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
2. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, et al. (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355: 666-674.
3. Nygaard TK, DeLeo FR, Voyich JM, (2008) Community-associated methicillin-resistant Staphylococcus aureus skin infections: advances toward identifying the key virulence factors. Curr Opin Infect Dis 21: 147-152.
4. Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, et al. (2011) Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008. Clin Infect Dis 53: 144-149.
5. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, et al. (2010) Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 202: 1050-1058.
6. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, et al. (2005) Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 175: 3907-3919.
7. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, et al. (2006) Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194: 1761-1770.
8. Li M, Cheung GY, Hu J, Wang D, Joo HS, et al. (2010) Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J Infect Dis 202: 1866-1876.
9. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, et al. (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 106: 5883-5888.
10. Otto M, (2010) Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 64: 143-162.
11. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, et al. (2008) Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 198: 561-570.
12. Loughman JA, Fritz SA, Storch GA, Hunstad DA, (2009) Virulence gene expression in human community-acquired Staphylococcus aureus infection. J Infect Dis 199: 294-301.
13. Goerke C, Fluckiger U, Steinhuber A, Bisanzio V, Ulrich M, et al. (2005) Role of Staphylococcus aureus global regulators sae and sigmaB in virulence gene expression during device-related infection. Infect Immun 73: 3415-3421.
14. Li D, Cheung A, (2008) Repression of hla by rot is dependent on sae in Staphylococcus aureus. Infect Immun 76: 1068-1075.
15. Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS, (2006) Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 194: 1267-1275.
16. Pang YY, Schwartz J, Thoendel M, Ackermann LW, Horswill AR, et al. (2010) agr-Dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun 2: 546-559.
17. Nygaard TK, Pallister KB, Ruzevich P, Griffith S, Vuong C, et al. (2010) SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis. J Infect Dis 201: 241-254.
18. Sun F, Li C, Jeong D, Sohn C, He C, et al. (2010) In the Staphylococcus aureus two-component system sae, the response regulator SaeR binds to a direct repeat sequence and DNA binding requires phosphorylation by the sensor kinase SaeS. J Bacteriol 192: 2111-2127.
19. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O, (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13: 1405-1406.
20. Bubeck Wardenburg J, Schneewind O, (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205: 287-294.
21. Voyich JM, Vuong C, DeWald M, Nygaard TK, Kocianova S, et al. (2009) The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J Infect Dis 199: 1698-1706.
22. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, et al. (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367: 731-739.
23. Bruckner R, (1997) Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol Lett 151: 1-8.
24. Malone CL, Boles BR, Lauderdale KJ, Thoendel M, Kavanaugh JS, et al. (2009) Fluorescent reporters for Staphylococcus aureus. J Microbiol Methods 77: 251-260.
25. Dumont AL, Nygaard TK, Watkins RL, Smith A, Kozhaya L, et al. (2011) Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol 79: 814-825.
26. Montgomery CP, Boyle-Vavra S, Daum RS, (2010) Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One 5: e15177.
27. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, et al. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13: 1510-1514.
28. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, et al. (2010) Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A 107: 5587-5592.
29. Graves SF, Kobayashi SD, Braughton KR, Diep BA, Chambers HF, et al. (2010) Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants. Microbes Infect 12: 446-456.
30. Ventura CL, Malachowa N, Hammer CH, Nardone GA, Robinson MA, et al. (2010) Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS One 5: e11634.
31. Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, et al. (2011) Global changes in Staphylococcus aureus gene expression in human blood. PLoS One 6: e18617.
32. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, et al. (2009) Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 4: e7446.
33. Haslinger B, Strangfeld K, Peters G, Schulze-Osthoff K, Sinha B, (2003) Staphylococcus aureus alpha-toxin induces apoptosis in peripheral blood mononuclear cells: role of endogenous tumour necrosis factor-alpha and the mitochondrial death pathway. Cell Microbiol 5: 729-741.
34. Jonas D, Walev I, Berger T, Liebetrau M, Palmer M, et al. (1994) Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun 62: 1304-1312.
35. Valeva A, Walev I, Pinkernell M, Walker B, Bayley H, et al. (1997) Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A 94: 11607-11611.
36. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, Kennedy AD, Sampaio E, et al. (2010) Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2: 560-575.
37. O'Reilly M, Kreiswirth B, Foster TJ, (1990) Cryptic alpha-toxin gene in toxic shock syndrome and septicaemia strains of Staphylococcus aureus. Mol Microbiol 4: 1947-1955.
38. Christensson B, Hedstrom SA, (1986) Biochemical and biological properties of Staphylococcus aureus septicemia strains in relation to clinical characteristics. Scand J Infect Dis 18: 297-303.
39. Schlievert PM, Osterholm MT, Kelly JA, Nishimura RD, (1982) Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med 96: 937-940.
40. Clyne M, De Azavedo J, Carlson E, Arbuthnott J, (1988) Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome. J Clin Microbiol 26: 535-539.
41. Ragle BE, Bubeck Wardenburg J, (2009) Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect Immun 77: 2712-2718.
42. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, et al. (2011) Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 204: 937-941.
43. Menzies BE, Kourteva I, (2000) Staphylococcus aureus alpha-toxin induces apoptosis in endothelial cells. FEMS Immunol Med Microbiol 29: 39-45.
44. Miller LS, Cho JS, (2011) Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol.
45. Garcia-Lara J, Foster SJ, (2009) Anti-Staphylococcus aureus immunotherapy: current status and prospects. Curr Opin Pharmacol 9: 552-557.
46. Otto M, (2010) Novel targeted immunotherapy approaches for staphylococcal infection. Expert Opin Biol Ther 10: 1049-1059.